Skip to content

Effect of esketamine combined with dexmedetomidine on postoperative sleep quality in patients undergoing gynecological laparoscopy surgery

Effect of esketamine combined with dexmedetomidine on postoperative sleep quality in patients undergoing gynecological laparoscopy surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102662
Enrollment
Unknown
Registered
2025-05-19
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative sleep disturbance,POSD

Interventions

Esketamine group:Esketamine 0.3mg/kg/h was pumped continuously during the operation.
Dexmedetomidine group:During the operation, dexmedetomidine was injected continuously with 0.4ug /kg/h.
Esketamine combined with dexmedetomidine group:Intraoperatively, dexmedetomidine 0.4ug /kg/h and esketamine 0.3mg/kg/h were continuously pumped.
Normal saline group:Give equal volume normal saline.

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Women undergoing gynecological laparoscopy surgery under elective general anesthesia; 2. Age 18-65 years old; 3.ASA grade I - III; 4.BMI 18-30 kg/m^2; 5. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Preoperative sleep disorder, AIS > 6 or PSQI>=10; 2.Preoperative heart rate less than 55 beats per minute or the presence of atrioventricular block; 3.Acute cerebral hemorrhage or stroke; 4.Long-term use of psychotropic drugs; 5.Obstructive sleep apnea syndrome; 6.Chronic obstructive pulmonary disease; 7.Severe liver and kidney dysfunction; 8.A history of surgery within the last 3 months; 9.BMI >30 kg/m^2; 10.Allergy to the drugs involved in this study; 11.Patients with contraindications to the use of esketamine or dexmedetomidine; 12.Has been involved in other clinical studies; 13.Unable to understand the content of the relevant scale

Design outcomes

Primary

MeasureTime frame
Incidence of sleep disorders in the first three nights after surgery;

Secondary

MeasureTime frame
Anxiety and depression score;Postoperation pain;Postoperative recovery quality;Postoperative adverse events;The first time of the postoperative exhaust;Postoperative nausea and vomiting score;

Countries

China

Contacts

Public ContactChen Xiuxia

The Affiliated Hospital of Xuzhou Medical University

cxxlxy@sina.com+86 180 5226 8332

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026